A major milestone has been achieved in the advocacy for Measles-Rubella (MR) Vaccine Introduction in Nigeria! Following a high-level engagement with the Director-General of the Budget Office, Mr. Tanimu Yakubu, on Friday, February 15, we are thrilled to announce a significant breakthrough:

Dedicated Funding for MR Vaccine in the 2025 Budget

For the first time, funding for #MRVaccine4Nigeria has been ring-fenced within the service-wide vote, ensuring sustainable financing for this critical immunization initiative. This commitment marks a major step toward enhancing national immunization efforts, reducing child mortality, and protecting millions of children from measles and rubella.

Why This Matters

💰 Sustainable Funding – The allocation guarantees a steady financial commitment for MR vaccine procurement and distribution.

🛡️ Stronger Immunization Programs – With secured funding, routine and supplementary immunization activities can be effectively planned and executed.

🤝 National Health Prioritization – The government’s commitment reinforces the importance of immunization as a national priority, driving better health outcomes.

What’s Next?

With this landmark achievement, the focus now shifts to creating more awareness and ensuring widespread vaccine access across Nigeria. We remain committed to collaborating with key stakeholders, government agencies, and partners to drive vaccination coverage and protect future generations.